Up to now, no adequate and well-controlled reproduction studies have been conducted in humans and animals to determine its effects on pregnant women.[24] However, there is also no reports of maternal or fetal harms with the ingestion of normal daily recommended amounts during pregnancy
Access Our Fact Sheets Our quick and easy-to-read Fact Sheets answer frequently asked questions about 300+ maternal health conditions, medications, and other exposures during pregnancy and breastfeeding
Id always thought GLP-1s (like Ozempic) were only for people with a lot of weight to lose
S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J
This latest NHS deal for an innovative medicine will enable NHS patients in England to benefit from the latest application of the drug, semaglutide, that is already helping people as a treatment for obesity and type 2 diabetes contributing the 10 Year Health Plan ambition to prevent and manage more long-term conditions in a way that avoids the need for emergency care. Semaglutide is already available on the NHS in England as treatment option for people with obesity, when offered through specialist weight management services in line with NICE guidance, and Ozempic (another brand name for semaglutide) is widely prescribed by the NHS as a treatment for people with type 2 diabetes